Dashboard
1
The company has declared Negative results for the last 4 consecutive quarters
- OPERATING CASH FLOW(Y) Lowest at VND -9,730.1 MM
- DEBT-EQUITY RATIO (HY) Highest at 5.39 %
- INTEREST COVERAGE RATIO(Q) Lowest at 7,704.26
2
With ROE of 32.31%, it has a expensive valuation with a 4.75 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
VND 1,201,102 Million (Small Cap)
15.00
NA
4.87%
-0.17
32.31%
4.70
Revenue and Profits:
Net Sales:
138,608 Million
(Quarterly Results - Mar 2026)
Net Profit:
22,925 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.71%
0%
0.71%
6 Months
-17.54%
0%
-17.54%
1 Year
22.98%
0%
22.98%
2 Years
37.08%
0%
37.08%
3 Years
84.03%
0%
84.03%
4 Years
101.74%
0%
101.74%
5 Years
93.79%
0%
93.79%
Pharmedic Pharmaceutical Medicinal JSC for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.51%
EBIT Growth (5y)
4.07%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.56
Sales to Capital Employed (avg)
1.78
Tax Ratio
20.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
76.89%
ROE (avg)
21.70%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
4.75
EV to EBIT
12.21
EV to EBITDA
10.73
EV to Capital Employed
4.56
EV to Sales
2.19
PEG Ratio
NA
Dividend Yield
4.82%
ROCE (Latest)
37.34%
ROE (Latest)
32.31%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
Mildly Bearish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
138,608.20
162,124.20
-14.50%
Operating Profit (PBDIT) excl Other Income
33,623.80
25,160.90
33.64%
Interest
436.40
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
22,924.70
17,862.10
28.34%
Operating Profit Margin (Excl OI)
210.00%
132.20%
7.78%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -14.50% vs 28.14% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 28.34% vs -7.84% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
546,566.50
498,185.00
9.71%
Operating Profit (PBDIT) excl Other Income
109,908.30
101,916.30
7.84%
Interest
302.50
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
60,082.60
58,497.20
2.71%
Operating Profit Margin (Excl OI)
179.10%
181.60%
-0.25%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 9.71% vs 2.68% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 2.71% vs -4.11% in Dec 2024
About Pharmedic Pharmaceutical Medicinal JSC 
Pharmedic Pharmaceutical Medicinal JSC
Pharmaceuticals & Biotechnology
Pharmedic Pharmaceutical Medicinal Joint Stock Company is a Vietnam-based company principally engaged in the manufacturing and distributing of pharmaceutical products, medicines, cosmetic and other products used in the healthcare sector. In addition, the Company is involved in the provision of printing services of plastic, paper and aluminum packagings. Moreover, it is active in the manufacture and trading of chemical products, such as pesticides and detergents for household and medical usage. During the year ended December 31, 2012, 97.24% of the Company's total revenue came from the sale of finished products. As of December 31, 2012, the Company was an affiliate of Saigon Pharmaceutical Company Limited (SAPHARCO), and it had a factory in Ho Chi Minh City, Vietnam.
Company Coordinates 
Company Details
367 Nguyen Trai, Phuong Nguyen Cu Trinh, Quan 1 HO CHI MINH None : None
Registrar Details






